Bluejay Diagnostics, Inc. (BJDX)

Last Closing Price: 1.80 (2026-11-19)

Company Description

Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused on developing near-patient products for triage, diagnosis and monitoring of disease progression. Bluejay Diagnostics Inc. is based in ACTON, Mass.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) --
Net Income (Most Recent Fiscal Year) $-6.85M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 0.27
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -113.79%
Return on Assets (Trailing 12 Months) -91.42%
Current Ratio (Most Recent Fiscal Quarter) 3.91
Quick Ratio (Most Recent Fiscal Quarter) 3.91
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $6.66
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) --
Stock
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Common Shares Outstanding 1.12M
Free Float 1.05M
Market Capitalization $2.04M
Average Volume (Last 20 Days) 0.06M
Beta (Past 60 Months) 0.92
Percentage Held By Insiders (Latest Annual Proxy Report) 6.10%
Percentage Held By Institutions (Latest 13F Reports) 18.47%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%